{"id":"W2621105275","doi":"10.1016/j.neuroimage.2017.05.058","title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease","year":2017,"lang":"en","type":"article","venue":"NeuroImage","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":483,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Avid Radiopharmaceuticals; University of California, San Diego; Genentech; National Institutes of Health; Takeda Pharmaceutical Company; IXICO; H. Lundbeck A/S; Servier; Eisai; Northern California Institute for Research and Education; Pfizer; Biogen; BioClinica; AbbVie; Roche; University of Southern California; Novartis Pharmaceuticals Corporation; U.S. Department of Defense; Eli Lilly and Company; Tau Consortium; Bristol-Myers Squibb; Alzheimer's Drug Discovery Foundation; Merck; Fujirebio Europe; Alzheimer's Association; Foundation for the National Institutes of Health; GE Healthcare; Alzheimer's Disease Neuroimaging Initiative","keywords":"Positron emission tomography; Biomarker; Pet imaging; Disease; Medicine; Neuroimaging; Alzheimer's disease; Neuroscience; Amyloid (mycology); Psychology; Pathology; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.070663374409627,"score_gpt":0.3928652282722133,"score_spread":0.3222018538625863,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}